Broadlane cuts deals with R2 and Varian

Article

Provider of cost management services Broadlane has designated R2 Technology as its exclusive provider of computer-aided detection systems. The company also cut a three-year agreement with Varian Medical Systems for the supply of radiotherapy systems. The

Provider of cost management services Broadlane has designated R2 Technology as its exclusive provider of computer-aided detection systems. The company also cut a three-year agreement with Varian Medical Systems for the supply of radiotherapy systems. The exclusive agreement with R2, which extends to Dec. 31, 2004, provides access for Broadlane customers to R2's ImageChecker CAD mammography system. Varian will offer Broadlane institutions a range of radiotherapy products including its Clinac medical linear accelerators, Millennium multileaf collimators, and PortalVision electronic portal imaging systems. Broadlane customers will also have access to imaging products from GE Medical Systems that Varian distributes in North America under a special See and Treat Cancer Care partnership agreement.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.